Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Aug 11, 2022 12:27pm
Cannacord co conference inNew York today
Amal presented
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 11, 2022 11:32am
RE:More activities and growth in the Knight team in Brazil
Thanks for the quick update Golden.
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Aug 11, 2022 9:02am
More activities and growth in the Knight team in Brazil
Growth in sales team & visits & product for Knight to come. - & this is just one of the territories. -commment by samira at the end of call! GI
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 11, 2022 8:32am
RE:RE:RE:RE:RE:Expectations
Exactly - and then things get a little cloudy ... but expected. 1. Great revenue increase 2. Costs going up as we return to the field and they increase R&D activity 3. Record
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Aug 11, 2022 7:57am
RE:RE:RE:RE:Expectations
Seems like you got your first two wishes! :) Happy for you, haha.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 11, 2022 7:30am
New Press Release - Knight Therapeutics Reports Second Quarter 2022 Results
-- Achieves Record Quarterly Revenues and EBITDA1 --MONTREAL, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its second quarter ended June 30...
read article.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Aug 11, 2022 12:53am
Jobs Market ... new additions
Here's another story ... Territory Manager for Montreal and Atlantic regions (Primary Care) Territory Manager for Hamilton, Niagara and S-W Ontario (Primary Care) Seems like reposts from pre
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Aug 10, 2022 10:10pm
RE:RE:I'm sure there was a trigger ...
Stories is all we have - you'll be listening to stories for a while yet. We are all just buying time as we wait - and wait we will until you don't anymore. How's that for specifics
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Aug 10, 2022 4:44pm
RE:I'm sure there was a trigger ...
At some point, this really needs to stop being all about Goodman and his adorable cleverness, and I say that time is today. It made sense to promote the brash front-man/visionary when this company was
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Aug 10, 2022 12:45pm
I'm sure there was a trigger ...
If you know the story about Goodman selling Paladin ... it was something like ... if he couldn't run it anymore (after the bike accident) then he didn't to own it. That's when he put
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Aug 09, 2022 11:36am
Just for fun - Paladin Watch ...
First time we're hearing this ... Interesting ... Endo (Paladin Acquirer) Update: The Company remains in constructive negotiations with an ad hoc group of first lien creditors, among other
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Aug 08, 2022 4:04pm
RE:RE:RE:RE:RE:RE:Expectations
Oh yeah, got it. Whatever happened to Brazil, by the way? I guess we'll know in a few days. :)
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Aug 08, 2022 1:51pm
RE:RE:RE:RE:RE:Expectations
I should have made a further comment on the EBITDA margin. The reason why I thought that this would be higher was because of Exelon. As we were/are in a transition period with Exelon, I had expected
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Aug 08, 2022 12:42pm
Updated Presentation
Not much changed, I believe, except for the achievements page: https://www.gud-knight.com/wp-content/uploads/GUD-Corp-presentation_08-05-2022.pdf
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada